Annual Report 2025

NOTESTOTHE CONSOLIDATED FINANCIAL STATEMENTS For the year ended 31 December 2025 137 The United Laboratories International Holdings Limited Annual Report 2025 37. FINANCIAL INSTRUMENTS (Continued) Financial risk management objectives and policies (Continued) Credit risk and impairment assessment (Continued) The tables below detail the credit risk exposures of the Group’s financial assets at 31 December 2025 and 2024 which are subject to ECL assessment: External Internal Gross credit credit 12m or carrying 2025 Notes rating rating lifetime ECL amount RMB’000 Pledged bank deposits 25 Aa2 to Baa3 N/A 12m ECL 628,503 Bank balances 25 Aa1 to Baa3 N/A 12m ECL 10,605,822 Other receivables and refundable deposits 24 N/A Note 1 12m ECL 106,404 Consideration receivables 24 N/A Note 4 Lifetime ECL (credit-impaired) 339,574 Banker’s acceptance bills receivables 24 A1 to Caa2 N/A 12m ECL 1,982,202 Trade receivables 24 N/A Note 2 Lifetime ECL (provision matrix) 1,578,653 Trade receivables 24 N/A Note 2 Lifetime ECL (individual assessment) 669,917